Safety Study of Galantamine in Tic Disorders

• Status: Terminated
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions, etc.) will also be examined.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Parkinson's Disease and Movement Disorders Center
• Collaborator: Ortho-McNeil Neurologics, Inc.
• Treatments: Galantamine

Criteria

Inclusion Criteria:

• DSM IV criteria for the diagnosis of Tourette's syndrome, chronic motor or chronic vocal tic disorder

• Accepted method of birth control

Exclusion Criteria:

• Preganancy or nursing

• Unstable medical illness

• Unstable psychiatric illness